Riskpilot← Back to searchSign inGet full accessUNO VITA AS
ASActiveOrg 994731742Sjøgata 15, 1516 MossWholesale of pharmaceutical and medical goods · NACE 4646Est. 20095 employeeswww.unovita.com
Revenue 2024
NOK 8,7M
-9% vs 2023
EBITDA margin
2.3%
-74% vs 2023
Equity ratio
76.2%
Financial strength
Net profit 2024
NOK 9K
-98% vs 2023
| Revenue | NOK 8,7M | -9% |
| EBITDA | NOK 202K | -74% |
| Net profit | NOK 9K | -98% |
| Total assets | NOK 3,4M | -2% |
| Equity | NOK 2,6M | +0% |
| Employees | 5 | — |
Legal name
UNO VITA AS
Org number
994731742
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. november 2009
Share capital
NOK 1 570 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Styrets leder og ett styremedlem i fellesskap. Daglig leder og styrets leder i fellesskap.
Company purpose
Forskning, utvikling, behandling, kurs, kompetanseheving, rådgivning, informasjonsformidling, salg og distribusjon av medisinske produkter og metoder innen helsesektoren, drift av medisinsk klinikk og forskningsinstitusjon samt investeringer og deltagelse i andre virksomheter.
Address
Sjøgata 15, 1516 Moss
Website
www.unovita.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 461 | 8 823 | 9 484 | 9 584 | 8 682 |
| Staff expenses | −849 | −1 090 | −1 085 | −1 298 | −1 489 |
| EBITDA | 1 037 | 940 | 837 | 765 | 202 |
| Depreciation & amort. | −0 | −0 | −2 | −33 | −33 |
| EBIT | 1 037 | 940 | 836 | 732 | 169 |
| Net financials | −174 | −216 | −257 | −210 | −126 |
| Profit before tax | 863 | 724 | 578 | 522 | 42 |
| Tax | −0 | 0 | 148 | 127 | 33 |
| Net profit | 863 | 724 | 430 | 395 | 9 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 941 | 3 185 | 3 450 | 3 455 | 3 383 |
| Equity | 1 019 | 1 743 | 2 174 | 2 568 | 2 577 |
| Long-term debt | 280 | 0 | 0 | 1 | 0 |
| Short-term debt | 642 | 1 442 | 1 277 | 886 | 806 |
| Total debt | 922 | 1 442 | 1 277 | 887 | 806 |
EBITDA margin
2.3%
This company
15.8%
Market median
-85% vs market
20202024
Equity ratio
76.2%
This company
38.2%
Market median
+99% vs market
20202024
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20202024
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20202024
Asset turnover
2.57×
This company
1.12×
Market median
+129% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 12.74% | 12.74% | 2024 | |
| Individual | 9.62% | 9.62% | 2022 | |
| Individual | 9.62% | 9.62% | 2024 | |
| Company | 6.37% | 6.37% | 2024 | |
| Company | 2.39% | 2.39% | 2024 | |
| Company | 2.39% | 2.39% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of UNO VITA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Fredrik Poleszynski | Chairman | 0 companies |